Genomics increase accuracy in pediatric melanoma diagnosis
Source: Helio, March 2023
Key takeaways:
- Genomics increased accuracy in distinguishing between lesion types.
- Pediatric melanoma accounts for less than 1% of all melanomas.
NEW ORLEANS — Integrating genomic testing along with clinical and pathology information will lead to increased accuracy and detection of melanoma in pediatric patients, according to a speaker here.
“This concept of pediatric melanoma has evolved over the year, and now I think we finally have the tools to put everything together,” Alberto S. Pappo, MD, of St. Jude Children’s Research Hospital in Memphis, Tennessee, told Healio. “An integrated analysis of lesions will ultimately give us a better idea of how a lesion is going to behave in a child and will guide us through therapy.”